SEC Form 4 · accession 0002144116-26-000005
ORAGENICS INC · OGEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John Spencer
Officer — Chief Financial Officer
Period of report
Jul 1, 2026
Accepted (ET)
Jul 7, 2026 · 5:51 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001174940
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $0.59 | Jul 1, 2026 | A | 55,900 | A | — | Jul 1, 2036 | Common Stock | 55,900 | 55,900 | D |
Explanation of responses
- F1Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended. One fifth of the options vest on the grant date and the remainder of the options subsequently vest in equal annual installments over the first, second, third and fourth anniversary of the grant date upon the continued performance of services by the Reporting Person to the Company through the vesting dates. The option exercise price is the Company's closing price on the date of grant.